Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress

Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress

<p>Abstract</p> <p>Background</p> <p>Endocrine FGF19 and FGF21 exert their effects on metabolic homeostasis through fibroblast growth factor receptor (FGFR) and co-factor betaKlotho (KLB). Ileal FGF19 regulates bile acid metabolism through specifically FGFR4-KLB in hepa...

Full description

Bibliographic Details
Main Authors:	Yang Chaofeng, Wang Cong, Ye Min, Jin Chengliu, He Weimin, Wang Fen, McKeehan Wallace L, Luo Yongde
Format:	Article
Language:	English
Published:	BMC 2012-10-01
Series:	Nutrition & Metabolism
Subjects:	Adipose tissue Fibroblast growth factor FGF Fibroblast growth factor receptor FGFR Hepatic steatosis Hepatic stress Lipid metabolism Starvation
Online Access:	http://www.nutritionandmetabolism.com/content/9/1/94

Similar Items

Recombinant expression in E. coli of human FGFR2 with its transmembrane and extracellular domains
by: Adam Bajinting, et al.
Published: (2017-06-01)

Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress
by: Arianna Giacomini, et al.
Published: (2020-12-01)

Biological Significance and Targeting of the FGFR Axis in Cancer
by: Athina-Myrto Chioni, et al.
Published: (2021-11-01)

Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers
by: Khine S. Shan, et al.
Published: (2024-01-01)

Fibroblast growth factor receptor 4 (FGF4) and fibroblast growth factor 19 (FGFR19) autocrine enhance brest cancer cells survival
by: Tiong, Kai Hung, et al.
Published: (2016)

Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value
by: Alessio Ardizzone, et al.
Published: (2023-03-01)

Melatonin Suppresses Oral Squamous Cell Carcinomas Migration and Invasion through Blocking FGF19/FGFR 4 Signaling Pathway
by: Leilei Wang, et al.
Published: (2021-09-01)

Identification of a peptide antagonist of the FGF1–FGFR1 signaling axis by phage display selection
by: Magdalena Lipok, et al.
Published: (2019-05-01)

Dissecting the Interaction of FGF8 with Receptor FGFRL1
by: Lei Zhuang, et al.
Published: (2020-10-01)

FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas
by: Christopher I. Milton, et al.
Published: (2022-03-01)

FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention
by: Antonella De Luca, et al.
Published: (2020-09-01)

FGFR1–4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer
by: Joanna Moes-Sosnowska, et al.
Published: (2022-09-01)

Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling
by: Alexandru Nita, et al.
Published: (2021-06-01)

The role of fibroblast growth factor 18 in cancers: functions and signaling pathways
by: Yiming Zhou, et al.
Published: (2023-05-01)

Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications
by: Giovanni Vitale, et al.
Published: (2021-04-01)

Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche
by: Tatjana Seitz, et al.
Published: (2022-09-01)

Association of Serum Fibroblast Growth Factor 23 Levels with the Presence and Severity of Hepatic Steatosis Is Independent of Sleep Duration in Patients with Diabetes
by: Hu X, et al.
Published: (2020-04-01)

Patient Selection Approaches in FGFR Inhibitor Trials—Many Paths to the Same End?
by: Peter Ellinghaus, et al.
Published: (2022-10-01)

Case report: Pemigatinib-induced retinopathy: a serial examination of subretinal fluid secondary to an FGFR inhibitor
by: Daniel Barmas-Alamdari, et al.
Published: (2024-01-01)

FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target?
by: Csongor G. Lengyel, et al.
Published: (2022-01-01)

18F-labeled FGFR1 peptide: a new PET probe for subtype FGFR1 receptor imaging
by: Yang Chen, et al.
Published: (2023-04-01)

Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations
by: Patrick C. Lee, et al.
Published: (2021-04-01)

Correlation between different FGFR1 mutations and congenital hypogonadotropic hypogonadism
by: YANG Yufan, WANG Xi, NIE Min, WU Xueyan, MAO Jiangfeng
Published: (2023-05-01)

Fibroblast Growth Factor 2 Protein Stability Provides Decreased Dependence on Heparin for Induction of FGFR Signaling and Alters ERK Signaling Dynamics
by: Zuzana Koledova, et al.
Published: (2019-12-01)

Fibroblast growth factor 10 attenuates chronic obstructive pulmonary disease by protecting against glycocalyx impairment and endothelial apoptosis
by: Tian Jiang, et al.
Published: (2022-10-01)

Interleukin-17 receptor D (Sef) is a multi-functional regulator of cell signaling
by: Shivangi Pande, et al.
Published: (2021-01-01)

Novel <i>FGFR1</i> Variants Are Associated with Congenital Scoliosis
by: Shengru Wang, et al.
Published: (2021-07-01)

Morphometric analysis of the growth factors influence on fibroblastic phase of inflammation at experimental myocardial infraction
by: M. G. Shurygin, et al.
Published: (2014-05-01)

FGFR families: biological functions and therapeutic interventions in tumors
by: Qing Liu, et al.
Published: (2023-10-01)

Metabolic effects of FGF-21: thermoregulation and beyond
by: Bin eNi, et al.
Published: (2015-09-01)

FGF23, Biomarker or Target?
by: Cristian Rodelo-Haad, et al.
Published: (2019-03-01)

Skeletal FGFR1 signaling is necessary for regulation of serum phosphate level by FGF23 and normal life span
by: Yuichi Takashi, et al.
Published: (2021-09-01)

Activated FGFR3 suppresses bone regeneration and bone mineralization in an ovariectomized mouse model
by: Itaru Kawashima, et al.
Published: (2023-03-01)

Induced maturation of hepatic progenitor cells in vitro
by: Y. Bi, et al.
Published: (2013-08-01)

Derazantinib Inhibits the Bioactivity of Keloid Fibroblasts via FGFR Signaling
by: Shuqia Xu, et al.
Published: (2023-12-01)

Topical fibroblast growth factor‐2 for treatment of chronic tympanic membrane perforations
by: Felipe Santos, et al.
Published: (2020-08-01)

A Novel <em>FGFR1</em> Missense Mutation in a Portuguese Family with Congenital Hypogonadotropic Hypogonadism
by: Lúcia Fadiga, et al.
Published: (2022-04-01)

GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells Toward Breast Tumor Progression
by: Maria Francesca Santolla, et al.
Published: (2019-03-01)

Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness
by: Elena Poli, et al.
Published: (2022-12-01)

The FGFR Family Inhibitor AZD4547 Exerts an Antitumor Effect in Ovarian Cancer Cells
by: Yu Ran Na, et al.
Published: (2021-10-01)